Identification of naturally occurring drug-resistant mutations of SARS-CoV-2 papain-like protease
Abstract The SARS-CoV-2 papain-like protease (PLpro) is a cysteine protease that cleaves viral polyproteins and antagonizes the host immune response during viral replication. Jun12682 and PF-07957472 are the first-in-class PLpro inhibitors showing potent in vivo antiviral efficacy in mouse models. I...
Saved in:
| Main Authors: | Haozhou Tan, Qianru Zhang, Kyriakos Georgiou, Siyu Zhang, Kan Li, George Lambrinidis, Antonios Kolocouris, Xufang Deng, Jun Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-025-59922-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Statine-based peptidomimetics as SARS-CoV-2 Papain-like protease inhibitors: in Silico and in vitro studies
by: Raiane Dandara Pereira Pimentel, et al.
Published: (2025-07-01) -
The Virtual Screening and Molecular Docking Study of New Inhibitors for SARS-COV-2 Papain-Like Protease (PLpro)
by: Necmettin Pirinççioğlu, et al.
Published: (2025-05-01) -
Discovery of orally bioavailable SARS-CoV-2 papain-like protease inhibitor as a potential treatment for COVID-19
by: Yongzhi Lu, et al.
Published: (2024-11-01) -
Inhibition of MERS-CoV papain-like protease by sunitinib: In vitro and in silico investigations
by: Ahmed L. Alaofi, et al.
Published: (2025-04-01) -
Integrating Molecular Dynamics, Molecular Docking, and Machine Learning for Predicting SARS-CoV-2 Papain-like Protease Binders
by: Ann Varghese, et al.
Published: (2025-07-01)